FreeInvestmentReport.com Alert Tracks Tuesday Stocks With Potential: Advanced Micro Devices Inc., American
* Reuters is not responsible for the content in this press release.
LAS VEGAS, NEVADA, Jun 30 (MARKET WIRE) --
FreeInvestmentReport.com, a premier micro cap and penny stock investment
research firm, is pleased to offer its stock alerts service to the
investing community. FreeInvestmentReport alerts investors to stocks
market wide with a primary focus on micro and small cap stocks (penny
stocks) that provide our subscribers with gains between 100% - 2000%. In
order to receive our FREE report and start cashing in simply visit:
http://www.freeinvestmentreport.com/
FreeInvestmentReport Issues a Tuesday Midday Alert for:
Advanced Micro Devices Inc - an innovative technology company dedicated
to producing new generations of microchips. They have a head start in a
race with Intel Corp. to be the lead provider of chips for a new batch of
cheaper notebooks. In today's trading, AMD is leading the tech sector
back to positive territory.
American International Group - provides insurance and financial services.
AIG is down sharply after updating the risk factors in its annual report,
disclosing that valuation declines on credit-default swaps sold to
European banks could have a "material adverse effect" on the its results.
AIG also stated that the risk of losses on these derivatives may last
"longer than anticipated". Clearly, AIG is nowhere close to being out of
trouble and the bad news continues to hammer their stock price.
Ford Motor Co: is the world's fourth largest automotive manufacturer by
production volume and the only US based automaker not to receive a
government bailout. Ford has plans to begin producing and selling some of
its European models (such as the Mondeo and European version of the
Focus) in North America. This allows them to quickly bring in demand fuel
efficient cars to market without having to invest the resources to create
an entirely new automobile. With strong customer loyalty, cost savings
achieved through new labour contracts and relative financial health, we
think Ford is poised to grow. Shares of Ford are up 145.9% so far this
year!
Geron Corp: is a developer of first-in-class biopharmaceuticals for the
treatment of cancer and chronic degenerative diseases, including spinal
cord injury, heart failure and diabetes. They announced today that that
have reached an exclusive license and alliance agreement with GE
Healthcare, (a unit of General Electric Co.), to develop and
commercialize cellular assay products derived from human embryonic stem
cells for use in drug discovery, development and toxicity screening.
Now more than ever investors are looking to grab hold of publications
that can add value to their wallets. At FreeInvestmentReport, our reports
include trustworthy and comprehensive research, in depth due diligence
and technical analysis in order for our subscribers to track solid penny
stocks, small and micro cap market wide. At FreeInvestmentReport we only
alert our subscribers to stocks we are 100% sold on because we strongly
believe that nothing speaks louder than the collective success of our
subscribers. That is why we work diligently to bring our subscribers what
the other micro cap and penny stock pick reports and newsletters only
promise, true penny stock winners.
Find out what our subscribers already know, simply subscribe to our
newsletter today!
FreeInvestmentReport.com Disclosure
FreeInvestmentReport is not a registered investment advisor and nothing
contained in any materials should be construed as a recommendation to buy
or sell securities. Investors should always conduct their own due
diligence with any potential investment. FreeInvestmentReport is a wholly
owned entity of, a financial public relations firm. Please read our
report and visit our website, for complete risks and disclosures.
Contacts:
MicroCapster.com
Raphael Dominguez
(310) 817-6300
info@microcapster.com
www.MicroCapster.com
Copyright 2009, Market Wire, All rights reserved.
-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters